This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1989 Oct 14;2(8668):926.

doi: 10.1016/s0140-6736(89)91595-x.

Hazards of interferon therapy for HBV-seronegative chronic hepatitis

S Vento, G Di Perri, T Garofano, L Cosco, E Concia, T Ferraro, D Bassetti

PMID: 2571851
DOI: 10.1016/s0140-6736(89)91595-x

Case Reports

Hazards of interferon therapy for HBV-seronegative chronic hepatitis

S Vento et al. Lancet. 1989.

. 1989 Oct 14;2(8668):926.

doi: 10.1016/s0140-6736(89)91595-x.

Authors

S Vento, G Di Perri, T Garofano, L Cosco, E Concia, T Ferraro, D Bassetti

PMID: 2571851
DOI: 10.1016/s0140-6736(89)91595-x

No abstract available

PubMed Disclaimer

Similar articles

Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W. Propst A, et al. Dig Dis Sci. 1995 Oct;40(10):2117-8. doi: 10.1007/BF02208993. Dig Dis Sci. 1995. PMID: 7587776 No abstract available.
Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin.
Schvarcz R, Weiland O, Glaumann H. Schvarcz R, et al. Scand J Infect Dis. 1988;20(2):231-2. doi: 10.3109/00365548809032443. Scand J Infect Dis. 1988. PMID: 2456609
Interferon alpha 2-b therapy of HCV and nonBnonC chronic hepatitis.
Gargiulo M, Tarquini P, Di Ottavio L, Lattanzi E, De Nigris-Urbani A. Gargiulo M, et al. Arch Virol Suppl. 1992;4:304-5. doi: 10.1007/978-3-7091-5633-9_68. Arch Virol Suppl. 1992. PMID: 1450709 Clinical Trial.
[Therapy of viral hepatitis].
Rambusch EG, Manns MP. Rambusch EG, et al. Ther Umsch. 1998 Feb;55(2):71-6, 78-9. Ther Umsch. 1998. PMID: 9545847 Review. German.
[Treatment of chronic hepatitis B and C with alpha interferon].
Hess G. Hess G. Z Gastroenterol Verh. 1991 Mar;26:149-51. Z Gastroenterol Verh. 1991. PMID: 1714130 Review. German. No abstract available.

See all similar articles

Cited by

Diagnostic markers of viral hepatitis B and C.
Trépo C, Zoulim F, Alonso C, Petit MA, Pichoud C, Vitvitski L. Trépo C, et al. Gut. 1993;34(2 Suppl):S20-5. doi: 10.1136/gut.34.2_suppl.s20. Gut. 1993. PMID: 8314489 Free PMC article. Review.
Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response.
Mazzella G, Salzetta A, Casanova S, Morelli MC, Villanova N, Miniero R, Sottili S, Novelli V, Cipolla A, Festi D, et al. Mazzella G, et al. Dig Dis Sci. 1994 Apr;39(4):866-70. doi: 10.1007/BF02087435. Dig Dis Sci. 1994. PMID: 7908624 Clinical Trial.
[Interferon therapy and autoimmunity].
Fritzsch J, Krug J, Heberling HJ. Fritzsch J, et al. Med Klin (Munich). 1997 May 15;92(5):265-72. doi: 10.1007/BF03045081. Med Klin (Munich). 1997. PMID: 9244832 Review. German.
Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.
Meyer zum Büschenfelde KH, Dienes HP. Meyer zum Büschenfelde KH, et al. Virchows Arch. 1996 Sep;429(1):1-12. doi: 10.1007/BF00196814. Virchows Arch. 1996. PMID: 8865847 Review.
Clinical toxicity of the interferons.
Vial T, Descotes J. Vial T, et al. Drug Saf. 1994 Feb;10(2):115-50. doi: 10.2165/00002018-199410020-00003. Drug Saf. 1994. PMID: 7516663 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information